The company's revenue jumped 77% in Q3 to reach $401.6 million in Q3 2024, alongside a net income of $75.6 million. It now ...
Health and wellness platform Hims & Hers Health, Inc. (NYSE:HIMS), which has gained traction for its ...
Amazon announced Prime members can access new upfront pricing for treatment of five common conditions such as erectile ...
Hims & Hers Health, a telehealth company, is planning to offer a generic version of Novo Nordisk's diabetes drug, liraglutide ...
Investors with a lot of money to spend have taken a bullish stance on Hims & Hers Health HIMS. And retail traders ...
Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's ...
Walt Disney’s earnings beat Wall Street estimates, Super Micro Computer extends losses, and Cisco posts fiscal first-quarter ...
Hims & Hers (HIMS) is down -17.7%, or -$4.88 to $22.72. Published first on TheFly – the ultimate source for real-time, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback